Dr. Ashok Raj, MD

NPI: 1508840034
Total Payments
$178,221
2024 Payments
$31,728
Companies
24
Transactions
244

Payment Breakdown by Category

Other$74,992 (42.1%)
Consulting$59,836 (33.6%)
Research$19,502 (10.9%)
Travel$15,431 (8.7%)
Food & Beverage$8,450 (4.7%)
Education$11.33 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $70,292 31 39.4%
Consulting Fee $59,836 15 33.6%
Unspecified $19,502 16 10.9%
Travel and Lodging $15,431 59 8.7%
Food and Beverage $8,450 119 4.7%
Honoraria $2,585 2 1.5%
Compensation for serving as faculty or as a speaker for a medical education program $2,115 1 1.2%
Education $11.33 1 0.0%

Payments by Type

General
$158,719
228 transactions
Research
$19,502
16 transactions

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $39,168 25 $0 (2024)
PFIZER INC. $26,393 36 $0 (2024)
Global Blood Therapeutics, Inc. $23,845 18 $0 (2022)
BIOVERATIV THERAPEUTICS INC. $19,707 17 $0 (2018)
Shire North American Group Inc $17,629 29 $0 (2019)
Bayer Healthcare Pharmaceuticals Inc. $17,035 30 $0 (2023)
Genentech USA, Inc. $10,454 17 $0 (2022)
GENZYME CORPORATION $8,805 13 $0 (2024)
USWM, LLC $7,316 5 $0 (2024)
Terumo BCT, Inc. $2,250 2 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $31,728 52 JAZZ PHARMACEUTICALS INC. ($10,584)
2023 $34,702 35 PFIZER INC. ($15,800)
2022 $22,172 19 JAZZ PHARMACEUTICALS INC. ($12,531)
2021 $19,115 19 Global Blood Therapeutics, Inc. ($8,550)
2020 $8,360 7 Global Blood Therapeutics, Inc. ($6,110)
2019 $1,790 13 Merck Sharp & Dohme Corporation ($1,245)
2018 $36,182 46 BIOVERATIV THERAPEUTICS INC. ($19,707)
2017 $24,173 53 Bayer HealthCare Pharmaceuticals Inc. ($13,710)

All Payment Transactions

244 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/12/2024 CSL Behring Travel and Lodging Cash or cash equivalent $535.95 General
12/12/2024 CSL Behring Travel and Lodging Cash or cash equivalent $40.00 General
12/12/2024 CSL Behring Travel and Lodging Cash or cash equivalent $26.83 General
12/12/2024 CSL Behring Travel and Lodging Cash or cash equivalent $19.96 General
12/12/2024 CSL Behring Food and Beverage Cash or cash equivalent $14.79 General
12/10/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,790.00 General
Category: HEMATOLOGY/ONCOLOGY
12/06/2024 CSL Behring Travel and Lodging In-kind items and services $295.26 General
12/06/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $95.68 General
Category: ONCOLOGY
12/06/2024 CSL Behring Food and Beverage In-kind items and services $85.00 General
12/06/2024 CSL Behring Food and Beverage In-kind items and services $60.00 General
12/05/2024 CSL Behring Travel and Lodging In-kind items and services $218.85 General
11/14/2024 PFIZER INC. XYNTHA (Biological), BENEFIX, BEQVEZ Food and Beverage In-kind items and services $19.37 General
Category: HEMATOLOGY
11/05/2024 PFIZER INC. XYNTHA (Biological), BENEFIX, BEQVEZ Food and Beverage In-kind items and services $33.33 General
Category: HEMATOLOGY
10/22/2024 Novartis Pharmaceuticals Corporation ADAKVEO (Drug) Travel and Lodging In-kind items and services $380.81 General
Category: Hematology
10/22/2024 Novartis Pharmaceuticals Corporation ADAKVEO (Drug) Food and Beverage In-kind items and services $224.87 General
Category: Hematology
10/22/2024 Novartis Pharmaceuticals Corporation ADAKVEO (Drug) Travel and Lodging Cash or cash equivalent $79.00 General
Category: Hematology
10/22/2024 Novartis Pharmaceuticals Corporation ADAKVEO (Drug) Food and Beverage Cash or cash equivalent $38.22 General
Category: Hematology
10/22/2024 Novartis Pharmaceuticals Corporation ADAKVEO (Drug) Travel and Lodging In-kind items and services $33.46 General
Category: Hematology
10/21/2024 Novartis Pharmaceuticals Corporation ADAKVEO (Drug) Food and Beverage In-kind items and services $140.00 General
Category: Hematology
09/30/2024 PFIZER INC. OXBRYTA (Drug) Travel and Lodging In-kind items and services $83.58 General
Category: HEMATOLOGY
09/24/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Food and Beverage In-kind items and services $90.11 General
Category: HEMATOLOGY/ONCOLOGY
09/19/2024 GENZYME CORPORATION ALPROLIX (Biological) Food and Beverage In-kind items and services $119.70 General
Category: Hematology
09/08/2024 PFIZER INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
09/06/2024 PFIZER INC. OXBRYTA (Drug) Food and Beverage In-kind items and services $6.91 General
Category: HEMATOLOGY
08/19/2024 PFIZER INC. OXBRYTA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: HEMATOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A BIOVERATIV THERAPEUTICS INC. $10,569 6
Study to Determine the Safety and Efficacy of rFIXFc in Untreated Males With Severe Hemophilia B BIOVERATIV THERAPEUTICS INC. $8,933 10

About Dr. Ashok Raj, MD

Dr. Ashok Raj, MD is a Pediatrics healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508840034.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashok Raj, MD has received a total of $178,221 in payments from pharmaceutical and medical device companies, with $31,728 received in 2024. These payments were reported across 244 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($70,292).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Hematology-Oncology
  • Location Louisville, KY
  • Active Since 11/29/2005
  • Last Updated 06/24/2024
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1508840034

Products in Payments

  • OXBRYTA (Drug) $43,440
  • RYLAZE (Drug) $39,019
  • ELOCTATE (Drug) $10,569
  • HEMLIBRA (Biological) $10,240
  • ADVATE (Biological) $9,833
  • ALPROLIX (Drug) $8,933
  • Kovaltry (Drug) $7,205
  • Non-Covered $5,989
  • Spectra Optia Apheresis System (Device) $2,250
  • KEYTRUDA (Biological) $1,245
  • ADAKVEO (Drug) $896.36
  • SevenFact (Biological) $400.45
  • Endari (Drug) $273.87
  • ALTUVIIIO (Biological) $243.70
  • clonoSEQ (Device) $241.68
  • NO PRODUCT DISCUSSED (Drug) $205.17
  • GAMIFANT (Drug) $124.74
  • Kerendia (Drug) $124.74
  • Multiple Products (Biological) $124.57
  • ALPROLIX (Biological) $119.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Louisville